ProShares Ultra Nasdaq Biotechnology (BIB) Gained 5.74% or 2.94 To Price $54.15 On Friday


ProShares Ultra Nasdaq Biotechnology (BIB) gained 5.74% or 2.94 to $54.15. It is about 350000 shares traded, which is 231.84% compare to the average total volume 150968. The market cap of BIB is $362.81 million. The year to date change is -12.97%. The 52 week price range is from $44.62 to $69.62. Price of BIB have changed 2.48% during last week. It have changed -3.69% over last month, -8.81% over last 3 months, -2.81% over last 6 months and 7.67% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for BIB is 54.88. It is 1.35% above current price. The 200-day Moving Averages for BIB is 57.06. It is 5.37% above current price. The 52-week High is 69.62. It is 28.57% from the current price. The 52-week Low is 44.62. It is -17.60% from current price.

There are some statistics of BIB. It is has market cap $362.81 million. The share outstanding is 6.70 million. The average volume is 150968. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of BIB is 1.94%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of BIB is -6.53%.


Tags:

Share this post